Medicine and Dentistry
Antibiotic Resistance
27%
Antiinfective Agent
100%
Broad-Spectrum Antibiotic
11%
Clinical Trial
100%
Critical Illness
100%
Effect Size
5%
Escherichia coli
5%
Evacuation
5%
Extended Spectrum Beta Lactamase
5%
Gut
27%
Human Study
5%
Infection
100%
Infection Control
5%
Intensive Care Unit
44%
Inulin
100%
Lipopolysaccharide
5%
Microbiome
16%
Pathogen
22%
Placebo
5%
Plasmid
5%
Polysaccharide
5%
Prebiotics
100%
Prevalence
5%
Protocol Compliance
5%
Randomized Clinical Trial
5%
Real-Time Polymerase Chain Reaction
5%
Sepsis
5%
Short Chain Fatty Acid
16%
Superinfection
5%
Volunteer
5%
Wound
5%
Pharmacology, Toxicology and Pharmaceutical Science
Anaerobe
5%
Antibiotics
11%
Antiinfective Agent
100%
Antimicrobial Resistance
27%
Clinical Trial
100%
Critical Illness
100%
Escherichia coli
5%
Extended Spectrum Beta Lactamase
5%
Human Study
5%
Infection
100%
Infectious Agent
22%
Intestine Flora
16%
Inulin
100%
Lipopolysaccharide
5%
Microbiome
5%
Normal Human
5%
Placebo
5%
Polysaccharide
5%
Prevalence
5%
Randomized Clinical Trial
5%
Sepsis
5%
Short Chain Fatty Acid
16%
Superinfection
5%
Tolerability
5%
Wound
5%